According to the new study, one in eight people who recover from COVID-19 within six months of testing positive for the bug get their first psychiatric or neurological disease.
The Guardian reported that researchers surveyed 236,379 coronovirus Survivors, which found that the number rose to one in three when people with a previous history of psychiatric or neurological diseases were included.
In addition, the study found that one in nine patients were also diagnosed with conditions such as depression or stroke despite not being in the hospital when they were infected, the lead author of the university’s Department of Psychiatry, Dr. According to Max Tak. Oxford
The study, which has not yet been peer reviewed, used electronic health records to evaluate hospitalized and non-hospitalized patients with confirmed COVID-19 diagnoses.
The subjects were compared with one group diagnosed with influenza, according to the news outlet, and another diagnosed with respiratory tract infections between January 20 and December 13, 2020.
Their analysis accounted for factors such as age, race, gender, socio-economic status and any underlying physical and mental conditions.
According to the results, the probability of a COVID-19 survivor developing a psychiatric or neurological disease within six months was 33.6 percent; Nearly 13 percent of the survivors, in fact, received a diagnosis within that timeframe, the study found.
Researchers also discovered that most diagnoses were more common after subsequent encounters with the coronovirus with flu or other respiratory infections – including stroke, intracranial bleeding, dementia, and mental disorders.
Overall, COVID-19 was associated with an increased risk of these diagnoses, but the incidence was higher among those requiring hospital treatment, and significantly, among patients who developed brain disease, the Guardian reported.
Asked how long these conditions may last after diagnosis, Taquet told the outlet, “I don’t think we have the answer to that question yet.”
He said: “For a diagnosis like a stroke or an intracranial bleed, the risk decreases quite dramatically within six months … but for some neurological and psychiatric diagnoses, we don’t have an answer as to when it stopped. It is going to happen.”
Although the study does not prove that COVID-19 is directly behind psychiatric and neurological conditions, research suggests that the bug may have an effect on the brain and central nervous system.
Dr., a psychiatrist and clinical lecturer of King’s College Hospital. Tim Nicholson, who was not involved in the study, said the results would help researchers decide that neurological and psychiatric complications require more careful study.
“I think it specifically picks up the list of interests, especially some disorders of dementia and psychosis, and extends a little beyond the list of potential importance, including Gillian-Barré syndrome,” Guardian said.
Meanwhile, another study has found that coronovirus can live inside the brain of critically ill patients and trigger relapse in those who thought they had recovered.
Researchers at Georgia State University found that infecting the nasal passages of mice with the virus caused a rapid, rapid invasion of the brain leading to severe disease.
The lead researcher, Assistant Professor Mukesh Kumar, said the findings have implications for understanding the symptoms and severity of illness in people contracting the disease.
Kumar said, “Our view is that it is a respiratory disease, it is not necessary.” “Once it infects the brain, it can affect anything because the brain is controlling your lungs, heart, everything. The brain is a very sensitive organ. It is the central processor for everything.
The study is published in the journal Virus.